Fort Lauderdale, FL, December 20, 2006 - (Market Wire) - Sunwin Stevia International Coporation, a wholly owned subsidiary of Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), that is a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie Stevia in China, applauded the findings of a World Health Organization (WHO) report which found "stevioside has shown some evidence of pharmacological effects in patients with hypertension or with type-2 diabetes."

Earlier in 2006, the WHO performed a thorough evaluation of recent experimental studies of stevioside and steviols conducted on animals and humans, and concluded that "stevioside and rebaudioside A are not genotoxic in vitro or in vivo and that the genotoxicity of steviol and some of its oxidative derivatives in vitro is not expressed in vivo."

"While the WHO concluded that further research is needed to fully assess the health benefits of Stevia, we are confident that in 2007, international research will continue to prove that Stevia is a safe and effective alternative to other sweetening agents," said Steven Silbert, Executive Vice President of Sunwin Stevia International Corporation.

"As Sunwin prepares for the U.S. launch of the Only Sweet™ line of products, we believe Stevia use in the U.S. and around the world will continue to grow in 2007 and beyond," Mr. Silbert added, "Only Sweet™ is an all-natural, zero-calorie dietary supplement containing Stevia manufactured by Sunwin International Neutraceuticals. In fact, the WHO report estimated significant Stevia intake in various nations around the world. In both Japan and China, for example, the demand for Stevia is estimated at approximately 200 tons per year."

Mr. Silbert concluded, "As sugar consumption in the U.S. rises, along with serious medical conditions such as diabetes and obesity, it is more important than ever for people to utilize healthful alternatives like Stevia." We believe our "Only Sweet™" line of products is positioned perfectly as the best choice for today's health conscious consumers. We use proprietary technology to process the seed of the Stevia rebaudiana plant that enables us to produce what we believe to be the highest grade Stevia in the industry. Management believes our "Only Sweet™" line of products is far superior in taste than any other Stevia product and provides benefits that exceed those of any other synthetic sweeteners on the market."

Benford, D.J., DiNovi, M., Schlatter, J. (2006). "Safety Evaluation of Certain Food Additives: Steviol Glycosides". WHO Food Additives Series54: 140

Benford, D.J., DiNovi, M., Schlatter, J. (2006). "Safety Evaluation of Certain Food Additives: Steviol Glycosides". WHO Food Additives Series54: 136, 138

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) is engaged in the areas of essential traditional Chinese medicine, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. For more info about Sunwin, please visit http://www.sunwin.biz

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Reported results should not be considered as an indication of future performance. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact:

Steven Silbert
Executive Vice President
Tel: 954.724.2944

Or

Iris Shaffer
Director of Public Relations
Tel: 708.799.6284